ClinicaliQ Trial Snapshot
- Study of Inflammatory and Physiological Profiles of Healthy and Diseased Lung — Recruiting • Respiratory / COPD / Asthma • NCT06144476.
- What is being tested: This study investigates the inflammatory and physiological profiles in healthy lungs versus diseased lungs (specifically asthma and COPD), aiming to better understand the immunopathology underlying these two most common lung diseases.
- Patient eligibility overview: The trial includes participants with diagnosed asthma or COPD, alongside healthy control subjects, allowing direct comparison of disease mechanisms across patient populations.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
There are over 700,000 UK hospital admissions every year with lung disease symptoms. Two of the most common lung diseases contributing to these numbers are asthma and chronic obstructive pulmonary disease (COPD). The immunopathology of these diseases is not fully understood. Matched samples from the respiratory tract and circulation will be used to identify immune patterns throughout the respiratory system to elucidate the immunopathology of airway disease.
Eligibility Snapshot
- : * Participant is willing and able to give informed consent for participation in the study * Aged 18 years or above * Patient: known or suspected airway disease * Healthy volunteer: considered to be in good health with no significant comorbidity (immune disorder, cancer etc.)
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.